ZWJ Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $499K | Buy |
20,732
+306
| +1% | +$8.01K | 0.02% | 169 |
|
|
2026
Q1 | $574K | Sell |
20,426
-1,404
| -6% | -$37.4K | 0.02% | 147 |
|
|
2025
Q4 | $544K | Hold |
21,830
| – | – | 0.02% | 146 |
|
|
2025
Q3 | $556K | Buy |
21,830
+248
| +1% | +$6.12K | 0.02% | 145 |
|
|
2025
Q2 | $523K | Sell |
21,582
-1,552
| -7% | -$36.2K | 0.02% | 142 |
|
|
2025
Q1 | $586K | Buy |
23,134
+320
| +1% | +$8.37K | 0.02% | 136 |
|
|
2024
Q4 | $605K | Sell |
22,814
-1,412
| -6% | -$38.3K | 0.03% | 136 |
|
|
2024
Q3 | $701K | Sell |
24,226
-3,385
| -12% | -$98.7K | 0.03% | 128 |
|
|
2024
Q2 | $773K | Sell |
27,611
-1,536
| -5% | -$42.3K | 0.03% | 123 |
|
|
2024
Q1 | $809K | Sell |
29,147
-3,522
| -11% | -$97.7K | 0.04% | 118 |
|
|
2023
Q4 | $941K | Sell |
32,669
-9,940
| -23% | -$300K | 0.05% | 109 |
|
|
2023
Q3 | $1.41M | Buy |
42,609
+1,006
| +2% | +$35.6K | 0.08% | 92 |
|
|
2023
Q2 | $1.53M | Sell |
41,603
-1,356
| -3% | -$52.8K | 0.08% | 93 |
|
|
2023
Q1 | $1.75M | Buy |
42,959
+373
| +0.9% | +$16.1K | 0.1% | 86 |
|
|
2022
Q4 | $2.18M | Buy |
42,586
+3,075
| +8% | +$147K | 0.12% | 80 |
|
|
2022
Q3 | $1.73M | Sell |
39,511
-4,938
| -11% | -$240K | 0.11% | 86 |
|
|
2022
Q2 | $2.33M | Buy |
44,449
+3,200
| +8% | +$163K | 0.14% | 74 |
|
|
2022
Q1 | $2.13M | Hold |
41,249
| – | – | 0.11% | 75 |
|
|
2021
Q4 | $2.44M | Buy |
41,249
+263
| +0.6% | +$13K | 0.12% | 75 |
|
|
2021
Q3 | $1.76M | Buy |
40,986
+778
| +2% | +$34.5K | 0.1% | 82 |
|
|
2021
Q2 | $1.57M | Buy |
40,208
+300
| +0.8% | +$11.7K | 0.09% | 84 |
|
|
2021
Q1 | $1.45M | Buy |
39,908
+1,584
| +4% | +$56.2K | 0.09% | 90 |
|
|
2020
Q4 | $1.41M | Buy |
38,324
+2,236
| +6% | +$82K | 0.1% | 87 |
|
|
2020
Q3 | $1.26M | Sell |
36,088
-4,583
| -11% | -$161K | 0.1% | 83 |
|
|
2020
Q2 | $1.26M | Sell |
40,671
-27,414
| -40% | -$931K | 0.11% | 78 |
|
|
2020
Q1 | $2.11M | Sell |
68,085
-3,186
| -4% | -$109K | 0.19% | 75 |
|
|
2019
Q4 | $2.65M | Buy |
71,271
+24,766
| +53% | +$882K | 0.18% | 73 |
|
|
2019
Q3 | $1.58M | Buy |
46,505
+642
| +1% | +$23.3K | 0.12% | 71 |
|
|
2019
Q2 | $1.89M | Sell |
45,863
-18
| -0% | -$715 | 0.15% | 73 |
|
|
2019
Q1 | $1.85M | Buy |
45,881
+4,701
| +11% | +$188K | 0.15% | 70 |
|
|
2018
Q4 | $1.71M | Buy |
41,180
+635
| +2% | +$26.4K | 0.16% | 71 |
|
|
2018
Q3 | $1.7M | Sell |
40,545
-408
| -1% | -$15.7K | 0.14% | 67 |
|
|
2018
Q2 | $1.41M | Buy |
40,953
+761
| +2% | +$26K | 0.12% | 70 |
|
|
2018
Q1 | $1.35M | Sell |
40,192
-25,122
| -38% | -$864K | 0.12% | 72 |
|
|
2017
Q4 | $2.24M | Sell |
65,314
-2,430
| -4% | -$82.9K | 0.18% | 72 |
|
|
2017
Q3 | $2.29M | Sell |
67,744
-1,493
| -2% | -$48K | 0.18% | 72 |
|
|
2017
Q2 | $2.21M | Sell |
69,237
-8,597
| -11% | -$271K | 0.18% | 73 |
|
|
2017
Q1 | $2.53M | Buy |
77,834
+42,869
| +123% | +$1.35M | 0.21% | 73 |
|
|
2016
Q4 | $1.08M | Buy |
34,965
+4,345
| +14% | +$133K | 0.1% | 85 |
|
|
2016
Q3 | $984K | Buy |
30,620
+437
| +1% | +$14.6K | 0.1% | 85 |
|
|
2016
Q2 | $1.01M | Buy |
30,183
+13
| +0% | +$415 | 0.1% | 87 |
|
|
2016
Q1 | $848K | Sell |
30,170
-210
| -0.7% | -$6K | 0.09% | 89 |
|
|
2015
Q4 | $930K | Buy |
30,380
+1,263
| +4% | +$39.7K | 0.1% | 90 |
|
|
2015
Q3 | $867K | Buy |
29,117
+949
| +3% | +$30.4K | 0.1% | 86 |
|
|
2015
Q2 | $897K | Sell |
28,168
-1,701
| -6% | -$55.4K | 0.09% | 86 |
|
|
2015
Q1 | $986K | Buy |
29,869
+1,581
| +6% | +$50.3K | 0.1% | 81 |
|
|
2014
Q4 | $836K | Buy |
28,288
+578
| +2% | +$16.6K | 0.08% | 87 |
|
|
2014
Q3 | $777K | Sell |
27,710
-370
| -1% | -$10.4K | 0.08% | 87 |
|
|
2014
Q2 | $790K | Buy |
28,080
+72
| +0.3% | +$2.05K | 0.09% | 86 |
|
|
2014
Q1 | $853K | Sell |
28,008
-1,404
| -5% | -$41.9K | 0.1% | 83 |
|
|
2013
Q4 | $855K | Hold |
29,412
| – | – | 0.1% | 84 |
|
|
2013
Q3 | $802K | Buy |
29,412
+254
| +0.9% | +$6.91K | 0.1% | 82 |
|
|
2013
Q2 | $775K | Buy |
+29,158
| New | +$806K | 0.1% | 81 |
|
Other funds holding PFE
ZWJ Investment Counsel's PFE Position: Q2 2026 in Review
ZWJ Investment Counsel increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $8.01K and bringing the position to 20,732 shares worth $499K. The position accounts for 0.02% of the portfolio, ranked #169.
ZWJ Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.65M in Q4 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- ZWJ Investment Counsel held 20,732 shares of Pfizer worth $499K as of Q2 2026.
- ZWJ Investment Counsel bought 306 Pfizer shares in Q2 2026, an estimated $8.01K.
- Pfizer made up 0.02% of ZWJ Investment Counsel's portfolio in Q2 2026, its #169 holding.
- ZWJ Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- ZWJ Investment Counsel's Pfizer position peaked at $2.65M in Q4 2019.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.